Basel, Switzerland, October 15, 2018 --(PR.com)-- The MPP annual event, organized by the Medtech & Pharma Platform international industry association, is the leading conference in the sector of combined products, bringing together key stake�holders from medtech and pharmaceutical companies with the aim to encourage cross-sectoral collaboration, foster innovation and enhance synergies.

Keynote speakers Michael Doherty of Foundation Medicine and Charles Bridges of Actelion will open the conference with insights into innovations at the intersection of pharma and medtech. Their presentations will be followed by a panel discussion featuring Matthew May of the European Patients� Forum, who will bring the patients� perspective on these innovative products.

Over the two days, six sessions will focus on current topics relating to pharmaceuticals, medical devices, in-vitro diagnostics and combined products. Internationally acknowledged experts will discuss regulatory trends, innovative technologies, combined products development, digital health, and management of patient data.

Ms F�rst-Ladani, President of the MPP association and CEO of SFL Regulatory Affairs & Scientific Communication commented: �We are proud to celebrate the 5th anniversary of the MPP annual event with an engaging program that gives attendees the opportunity to exchange knowledge and connect with international industry and regulatory experts. I am excited about the large number of senior professionals from international pharmaceutical and medtech companies attending the event this year.�

In addition to the program, table top exhibitions and 1-on-1 partnering meetings will take place during the conference breaks, to facilitate networking and business partnerships among participants.

The next year�s Medtech & Pharma Platform annual event will take place on 24-25 October 2019 in Basel.